Not Yet Recruiting
Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer
NCT07718854
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +20 more
- Locations
-
- Tufts Medical Center Boston, Massachusetts, United States